Merck KGaA
LSE:0O14
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck KGaA
LSE:0O14
|
DE |
|
H
|
Hancock Whitney Corp
F:HH1
|
US |
|
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
|
US |
Wall St Price Targets
0O14 Price Targets Summary
Merck KGaA
According to Wall Street analysts, the average 1-year price target for 0O14 is 146.55 EUR with a low forecast of 117.22 EUR and a high forecast of 188.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0O14's stock price target?
Price Target
146.55
EUR
According to Wall Street analysts, the average 1-year price target for 0O14 is 146.55 EUR with a low forecast of 117.22 EUR and a high forecast of 188.05 EUR.
What is the Revenue forecast for Merck KGaA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Merck KGaA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Merck KGaA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Merck KGaA?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Merck KGaA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 8 years is 12%.
